|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
||||||||||
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
||||
|
|
(in thousands) |
|
|||||||||||||
Cost of revenue |
|
$ |
633 |
|
|
$ |
679 |
|
|
$ |
1,168 |
|
|
$ |
6,758 |
|
Sales and marketing |
|
|
3,410 |
|
|
|
11,178 |
|
|
|
8,644 |
|
|
|
57,285 |
|
Research and development |
|
|
2,898 |
|
|
|
15,064 |
|
|
|
6,747 |
|
|
|
69,627 |
|
General and administrative |
|
|
3,074 |
|
|
|
11,262 |
|
|
|
5,782 |
|
|
|
52,259 |
|
Total stock-based compensation expense |
|
$ |
10,015 |
|
|
$ |
38,183 |
|
|
$ |
22,341 |
|
|
$ |
185,929 |
|
|
Procore Announces Third Quarter 2021 Financial Results
(1) Includes stock-based compensation expense as follows:
|
|
||||||
|
|
|||||||
|
|||||||
